Ginsenoside Rd Improves Learning and Memory Ability in APP Transgenic Mice

Alzheimer’s disease (AD) is a complicated neurodegenerative disease which causes memory loss and dementia. Many researchers have revealed the vital roles of β-amyloid proteins (Aβ) in the proceeds of AD. Aβ deposition in AD patients’ brains might function as immune stimulus, and inflammation is believed to play an important role in AD pathologically. We experimentally used amyloid β-protein precursor (APP) transgenic (Tg) mice in this study to further clarify the neuroprotective effects of ginsenoside Rd on AD and its possible mechanisms. It was found that Rd could improve learning and memory ability in APP Tg mice, probably through inhibiting the transcription activity of NFκB. With the activation of the NFκB pathway being suppressed, the reduction of pro-inflammatory cytokines and the generation of protective factors had been increased ultimately. In conclusion, Rd had a neuroprotective effect on APP Tg mice, and it can be used as an alternative drug therapy in AD patients for their memory dysfunction.

[1]  Ming Yan,et al.  Proteomic profiling of proteins in rat spinal cord induced by contusion injury , 2010, Neurochemistry International.

[2]  Jianming Lü,et al.  Ginseng compounds: an update on their molecular mechanisms and medical applications. , 2009, Current vascular pharmacology.

[3]  J. Hyun,et al.  Anti-inflammatory mechanism of ginseng saponins in activated microglia , 2009, Journal of Neuroimmunology.

[4]  Giselle Chamberlain,et al.  Recent advances into the understanding of mesenchymal stem cell trafficking , 2007, British journal of haematology.

[5]  Sung-soo Kim,et al.  Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. , 2005, Biological & pharmaceutical bulletin.

[6]  M. Mattson.  Pathways towards and away from Alzheimer's disease , 2004, Nature.

[7]  M. Baccarani,et al.  Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. , 2007, Blood.

[8]  Gang Zhao,et al.  Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A , 2013, Neurobiology of Disease.

[9]  H. Kajiyama,et al.  Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer , 2006, British Journal of Cancer.

[10]  E. Hirsch,et al.  Nuclear translocation of NF‐κB in cholinergic neurons of patients with Alzheimer's disease , 1997, Neuroreport.

[11]  D. Walsh,et al.  Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s Diseases , 2008, Molecular medicine.

[12]  K. Qin,et al.  Ginsennoside Rd Attenuates Cognitive Dysfunction in a Rat Model of Alzheimer’s Disease , 2012, Neurochemical Research.

[13]  S. Ghosh,et al.  IκB Kinases: Kinsmen with Different Crafts , 1999, Science.

[14]  R. Ferris,et al.  Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases , 2008, Proteomics. Clinical applications.

[15]  P. Wadhwa,et al.  Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. , 2005, Journal of reproductive immunology.

[16]  C. Eckman,et al.  Reductions in levels of the Alzheimer's amyloid β peptide after oral administration of ginsenosides , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  Russell G Foster,et al.  Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. , 2003, Nucleic acids research.